medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2014, Number 2

<< Back Next >>

Salud Mental 2014; 37 (2)

Revisión crítica de las fuentes de variabilidad en la medición de la prevalencia de esquizofrenia

Moreno-Küstner B, Martín C, Almenara J

Language: Spanish
References: 41
Page: 127-138
PDF size: 343.87 Kb.


ABSTRACT

Epidemiologic research plays a very relevant role to know the prevalence of schizophrenia. However, sometimes data from different studies are compared without taking into account some methodological questions that influence the results. This paper reviews different methodological factors that influence variability of rates in schizophrenia prevalence. Also, we provide some generic recommendations for measuring prevalence. We have revised 52 studies which offer prevalence rates of schizophrenia. A big difference appears in the prevalence rates of schizophrenia which range between 1 to 45 per 1000 inhabitants. The factors founded can be summarized as follows: 1. type of prevalence; 2. denominator population; 3. place of selection of cases; 4. classification issue; 5. diagnoses categories and 6. methods of diagnoses. In conclusion, in the epidemiological studies about schizophrenia prevalence we have to take into account the methodological factors involved in order to interprete and compare results from different studies.


REFERENCES

  1. Murray CJ, Lopez AD (eds). The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston: Harvard School of Public Health; 1996.

  2. Catalá-López F, Gènova-Maleras R, Álvarez-Martín E, Fernández de Larrea-Baz N et al. Carga de enfermedad en adolescentes y jóvenes en España. Rev Psiquiatr Salud Ment 2013;06:80-5.

  3. Jablensky A, Sartorius N, Ernberg G, Anker M et al. Schizophrenia: manifestations, incidence and course in different cultures. A world health organization ten-country study. Psychol Med 1992;20 (monog. supp.).

  4. Goldner E, Hsu L, Waraich P, Somers J. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 2002;47(9):833-843.

  5. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005;2 (5):413-433.

  6. Torrey EF. Prevalence studies in schizophrenia. Br J Psychiatry 1987;150:598-608.

  7. Eaton WW. Epidemiology of schizophrenia. Epidemiol Rev 1985;7:105- 126.

  8. Eaton WW. Updata on the epidemiology of schizophrenia. Epidemiol Rev 1991;13:320-328.

  9. McGrath JJ. The surprisingly rich contours of schizophrenia epidemiology. Arch Gen Psychiatry 2007;64:14-16.

  10. Fletcher RH, Fletcher SW, Wagner EH. Epidemiología clínica. Aspectos fundamentales. Barcelona: Masson, 2002.

  11. Përalä J, Suvisaari J, Saarni SI, Kuoppasalmi K et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007;64:19-28.

  12. MacMahon B, Pugh TF. Epidemiology: Principles and methods. Boston: Little, Brown; 1970.

  13. Mausner JS, Bahn AK. Epidemiology: An introductory text. Philadelphia: Philadelphia Saunders; 1974.

  14. Bolúmar F. Las medidas de frecuencia. En: Doménech (ed.). Diseño de estudios sanitarios. Estudios descriptivos. Barcelona: UD 2 Signo; 2000.

  15. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York: Van Nostrand Reinhold; 1982.

  16. Bolúmar F. Medición de los fenómenos de salud y enfermedad en epidemiología. En: Piédrola Gil (ed.). Medicina preventiva y salud pública. Décima edición. Barcelona: Masson; 2001.

  17. Rothman JK, Greenland S. Modern epidemiology. Segunda edición. Philadelphia: Lippincott Williams & Wilkins; 1998.

  18. Vázquez Barquero JL, Diez Marnique JF, Peña C, Aldama J et al. A community mental health survey in Cantabria: a general description of morbidity. Psychol Med 1987;17:227-241.

  19. Bhugra D. The global prevalence of schizophrenia. PLoS Med 2005;2(5):372-373.

  20. Jansson LB, Parnas J. Competing definitions of schizophrenia: What can be learned from polydiagnostic studies? Schizophr Bull 2007;33(5):1178-1200.

  21. Os J van, Hanssen M, Bijl Rv, Vollebergh W. Prevalence of psychotic disorder and community level of psychotic symptoms: an urban–rural comparison. Arch Gen Psychiatry 2001;58:663–668.

  22. Warner R, Girolamo G. Esquizofrenia. Epidemiología de los trastornos mentales y de los problemas psicosociales. Ginebra: Meditor; 1995.

  23. Organización Mundial de la Salud. Clasificación Internacional de Enfermedades. 10ª revisión. Ginebra: 1992.

  24. López Ibor JM. Manual diagnóstico y estadístico de los trastornos mentales: DSM-IV-TR. American Psychiatric Association. Barcelona: Masson; 2000.

  25. Kulhara P, Mattoo SK, Chandiramani K, Bhave S et al. Diagnostic systems for schizophrenia. A cross-sectional study concordance from India. Acta Psychiatr Scand 1986;74:55-61.

  26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5), 5ª edición. Arlington VA: 2013.

  27. Wing JK, Cooper JE, Sartorius N. The description and manual for the PSE and CATEGO system. Cambridge: Cambridge University Press; 1974.

  28. Wing JK, Babor T, Brugha Ts, Burke H et al. SCAN: Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990;47:489-593.

  29. Robins LN, Helzer JN, Crougham J, Ratcliff KS. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 1981,38:381-389.

  30. Robins LN, Wing J, Wittchen HU, Helzer JE et al. The composite international diagnostic interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry 1988;45:1069-1077.

  31. First MB, Gibbon M, Spitzer RL et al. User’s guide for the structured clinical interview for DSM-IV. Axis II personality disorders (SCID-II). Washington DC: American Psychiatric Press; 1997.

  32. Saha S, Chant D, Mcgrath J. Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues. Int J Methods Psychiatr Res 2008;17(1):55–61.

  33. Chien I, Chou Y, Lin C, Bih S et al. Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 2004;55:691-697.

  34. Bijl RV, Ravelli A, Van Zessen G. Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595.

  35. Häfner H, Heiden W. an der. The contribution of European case registers to research on schizophrenia. Schizophr Bull 1986;12:26-49.

  36. Freeman H, Henderson JH. Evaluation of comprehensive care of the mentally ill. Londres: Gaskell; 1991.

  37. Torres González F, Rosales Varo C, Moreno Küstner B. Prevalencia de la esquizofrenia. Monografías Psiquiatría 2002;2:2-6.

  38. Sartorius N, Jablensky A, Ernberg G, Leff J et al. Course of schizophrenia in different countries: some results of a WHO international comparative 5-year follow-up study. En: Häfner H, Gattaz WF, Janzarik W (eds). Search for the causes of schizophrenia. Berlin: Springer-Verlag: 1987.

  39. Keith SJ. Schizophrenic disorders in America. En: Robins L, Regier DA (eds.). Psychiatric disorders in America. Nueva York: Free Press; 1991; p. 33-51.

  40. Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey. Br J Psychiatry 2001;178:145-153.

  41. Moreno-Altamirano A, López-Moreno S, Corcho-Berdugo A. Principale medidas en epidemiologia. Salud Pública México 2000;42:337-348.




2020     |     www.medigraphic.com